Chronic News and Research

RSS

FDA approves Takeda's Entyvio for severe active ulcerative colitis and Crohn's disease

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., has announced that the United States (U.S.) Food and Drug Administration (FDA) simultaneously approved a new biologic therapy, Entyvio™ (vedolizumab), for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD).

21 May 2014

Two new studies aim to change HIV infections in children, maternal deaths due to HIV

HIV has been transformed into a chronic, manageable disease for most people living with HIV in the United States, where mother-to-child transmission of HIV is now a rare occurrence.

20 May 2014

Aradigm receives QIDP designation for its inhaled antibiotic candidate, Pulmaquin

Aradigm Corporation (the "Company") today announced that the U.S. Food and Drug Administration (FDA) has designated the Company's lead inhaled antibiotic candidate, Pulmaquin®, as a Qualified Infectious Disease Product (QIDP).

20 May 2014

BioLineRx announces financial results for Q1 2014, provides operational update

BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today reported its financial results for first quarter ended March 31, 2014.

20 May 2014

Novel drug for patients with inoperable CTEPH shows improvement in international trial

After a year of being treated with a novel drug, patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) and those with persistent or recurrent pulmonary hypertension after an operation for the disease showed sustained improvement in a multicenter, international trial presented at the 2014 American Thoracic Society International Conference.

20 May 2014

GSK reports positive results from Incruse Ellipta and Advair Diskus combination therapy in COPD patients

GlaxoSmithKline plc today presented data at the American Thoracic Society (ATS) from a late-stage clinical study.

20 May 2014

Internet-based physical activity can improve health-related quality of life in patients with COPD

A pedometer-based walking program supported by Internet-based instruction and support can improve health-related quality of life (HRQOL) in patients with chronic obstructive pulmonary disease (COPD), according to a new study presented at the 2014 American Thoracic Society International Conference.

20 May 2014

Holistic exercise program may improve physical, psychological wellbeing of dementia patients

While dementia patients can often suffer from depression and declining physical and mental ability, exercise has been shown to help improve both their physical and psychological wellbeing.

20 May 2014

Innate immune response may warn of chronic multisite musculoskeletal pain

An enhanced innate immune response may be an indicator of the onset or prolongation of chronic, multisite musculoskeletal pain, cross-sectional study findings suggest.

19 May 2014

Current smoking heralds worse outcomes in pneumococcal CAP

Hospital patients with pneumococcal community-acquired pneumonia have worse outcomes if they are current smokers than if they are non- or ex-smokers, results of a large observational study suggest.

19 May 2014

Researchers identify drugs to slow progression of idiopathic pulmonary fibrosis

Researchers in separate clinical trials found two drugs slow the progression of idiopathic pulmonary fibrosis, a fatal lung disease with no effective treatment or cure, and for which there is currently no therapy approved by the Food and Drug Administration.

19 May 2014

Majority of Americans experience foot pain, shows new study

The American Podiatric Medical Association (APMA) today announced the results of its Today's Podiatrist survey, which measures the public's attitudes toward foot health.

19 May 2014

DNA-directed RNA interference and hepatitis C: an interview with Carl Stubbings, Chief Business Officer, Benitec Biopharma

RNA interference (RNAi) is a naturally occurring process, which cells can use to silence, or ‘turn off’ unwanted genes.

From Quest Diagnostics 19 May 2014

Shire intends to submit NDA for lifitegrast to treat dry eye disease

Following a May 15, 2014, meeting with the U.S. Food and Drug Administration (FDA), Shire plc, the global specialty biopharmaceutical company, announces today that it intends to submit a New Drug Application for lifitegrast as a treatment for the signs and symptoms of dry eye disease in adults in the first-quarter 2015, as we complete remaining chemistry and manufacturing work.

19 May 2014

IFRC, IFPMA launch '4 Healthy Habits' initiative to combat noncommunicable diseases

The International Federation of Red Cross and Red Crescent Societies (IFRC) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) launch today, during a side event at the 67th World Health Assembly, a global initiative, called '4 Healthy Habits'.

19 May 2014

Ferring launches new interactive website Guts4life for people with IBD

Ferring Pharmaceuticals marks World IBD Day (May 19th) with the launch of Guts4life (www.guts4life.com), a new interactive website with information, support and inspiration for people concerned with Crohn's disease and ulcerative colitis, conditions known as inflammatory bowel diseases (IBD).

19 May 2014

Chronic News and Research

FDA approves Takeda's Entyvio for severe active ulcerative colitis and Crohn's disease

Two new studies aim to change HIV infections in children, maternal deaths due to HIV

Aradigm receives QIDP designation for its inhaled antibiotic candidate, Pulmaquin

BioLineRx announces financial results for Q1 2014, provides operational update

Novel drug for patients with inoperable CTEPH shows improvement in international trial

GSK reports positive results from Incruse Ellipta and Advair Diskus combination therapy in COPD patients

Internet-based physical activity can improve health-related quality of life in patients with COPD

Holistic exercise program may improve physical, psychological wellbeing of dementia patients

Innate immune response may warn of chronic multisite musculoskeletal pain

Current smoking heralds worse outcomes in pneumococcal CAP

Researchers identify drugs to slow progression of idiopathic pulmonary fibrosis

Majority of Americans experience foot pain, shows new study

DNA-directed RNA interference and hepatitis C: an interview with Carl Stubbings, Chief Business Officer, Benitec Biopharma

Shire intends to submit NDA for lifitegrast to treat dry eye disease

IFRC, IFPMA launch '4 Healthy Habits' initiative to combat noncommunicable diseases

Ferring launches new interactive website Guts4life for people with IBD

Convenient new treatment option for rheumatoid arthritis sufferers offers patient freedom and control of disease

ICD, CRT-D patients benefit to almost equivalent extent from home telemonitoring

PARADIGM-HF trial of LCZ696 for chronic heart failure stopped early for benefit

Patients with chronic pulmonary thromboembolic disease may benefit from PTE

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News